Drug Type Synthetic peptide |
Synonyms HPV-NIRD1 (CTMM/Leiden University) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Human Papillomavirus Infection | Phase 1 | NL | - | |
Human Papillomavirus Infection | Phase 1 | NL | - |